Jack Gierlich a healthcare marketer who began cannabis research upon introduction to the NY-Medical Cannabis Program in early 2016, since then Jack has worked on several abstracts ...view moreJack Gierlich a healthcare marketer who began cannabis research upon introduction to the NY-Medical Cannabis Program in early 2016, since then Jack has worked on several abstracts involved in the Cannabis space and worked with Dr Krishna to file adjunct therapy patents whilst also analyzing possible cannabis contraindications such as hormone fluctuations, CYP450 interactions, and more. Jack looks to further research possible applications for Cannabis, and more specifically some cannabinoids such as CBD, CBV, CBG in addressing neuropathic pain, and sleep disorders; while also assisting in the development of the NY-Cannabis space through market consulting.view less